Table 1.
Bivariate analysis of tuberculosis quality-of-care indicators
| Characteristic | All patients (N = 161 230) n (%) |
Women (n = 112 329) n (%) |
Men (n = 48 901) n (%) |
P value |
|---|---|---|---|---|
| Age, years, median [IQR] | 29 [21–40] | 28 [21–39] | 30 [21– 43] | <0.001 |
| Clinic site | ||||
| Aduku | 23 359 (14.5) | 17 112 (15.2) | 6 247 (12.8) | <0.001 |
| Kamwezi | 33 019 (20.5) | 21 766 (19.4) | 11 253 (23.0) | |
| Kasambya | 15 394 (9.6) | 9 639 (8.6) | 5 755 (11.8) | |
| Kihihi | 22 844 (14.2) | 16 014 (14.3) | 6 830 (14.0) | |
| Nagongera | 23 776 (14.8) | 16 886 (15.0) | 6 890 (14.1) | |
| Walukuba | 42 838 (26.6) | 30 912 (27.5) | 11 926 (24.4) | |
| Cough ≥2 weeks (among all patient encounters) | 3 308 (2.1) | 1 871 (1.7) | 1 437 (2.9) | <0.001 |
| Sputum AFB ordered (among patients with cough ≥2 weeks) | 1 744 (52.7) | 859 (45.9) | 885 (61.6) | <0.001 |
| Sputum AFB completed (among patients with AFB examination ordered) | 1 326 (76.0) | 633 (73.7) | 693 (78.3) | 0.024 |
| AFB-positive (among patients with AFB examination completed) | 214 (16.1) | 60 (9.5) | 154 (22.2) | <0.001 |
| Referred for anti-tuberculosis treatment (among patients found AFB-positive) | 160 (74.8) | 44 (73.3) | 116 (75.3) | 0.76 |
| Received ISTC-adherent care overall (among patients with cough ≥2 weeks) | 1 272 (38.5) | 617 (33.0) | 655 (45.6) | <0.001 |
IQR = interquartile range; AFB = acid-fast bacilli; ISTC = International Standards of Tuberculosis Care.11